Lack of financial and staff resources, poor clinical information systems, physician workload and resistance to change were all barriers to care using best management processes.
Read More »Issue 132 Item 1 Delaying and Preventing Beta-cell Dysfunction in Type 2 Diabete
Attention to certain toxicities can delay the deterioration of beta-cell function.
Read More »Issue 127 Item 2 Using Insulin Pumps at Time of Diagnosis for Type 1 Diabetes
A study, presented by Dr. Paolo Pozzilli of the Bio-Medical University Campus in Rome, suggests that an insulin pump may be the best way to control diabetes from the start.
Read More »Issue 128 Item 2 Improved Outcomes Using the Continuous Glucose Monitor (CGM) fo
Study shows improved outcomes with the use of the continuous glucose monitoring system (CGMS) designed for home use (MiniMed, Sylmar, California).
Read More »Issue 129 Item 2 Cost of Diabetes is Exploding
Cost of medical care for a person with diabetes: $10,071 per year, compared with $2,669 for a person without diabetes.
Read More »Issue 130 Item 2 Grand Parents Diets May Affect Grandkids’ Risk for Diabetes & C
We are what we eat, or so the saying goes, but new research suggests that we may be what our parents and grandparents ate as well.
Read More »Issue 131 Item 1 Vascular Surgery in Diabetes Widely Embraced
Vascular surgery should not be withheld from patients with diabetes. Even though during 5 years of follow-up, patients with diabetes had about a 50% mortality rate, compared with about a 25% rate among the other patients in the series.
Read More »Immunomodulation of Type 1 Diabetes: Raising the Bar
In the past several months I’ve written a few pieces about immunomodulation of type 1 diabetes, or attempts to suppress the immune attack on insulin-producing beta cells. These studies have involved compounds that rein in the immune system in a more or less specific way, and all have been tested …
Read More »Issue 127 Item 1 Optimize Control of Type 1 Diabetes From Start
More aggressive treatment for the newly diagnosed provide better outcomes in the future
Read More »Issue 128 Item 1 Metformin Therapy For Type 1 Improves Glycemic Control
Metformin reduces hepatic glucose and improves insulin sensitivity in type 1 diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.